The Schedule of Treatment and Control of Hypertension in Hemodialysis Patients and Renal Transplant Recipients in 2006 and 2014/2016

Abstract

Introduction Hypertension (HT) is often recognized in both hemodialysis (HD) and renal transplant recipients (RTRs). The aim of the study The treatment schedule and control of hypertension according to PTNT (Polish Hypertension Society), ESH (European Society of Hypertension) recommendations. Materials and Methods These observations were in two distinct periods of time 2006 and 2014/2016. In 2006 59 HD patients (average age 61.4 years), 330 RTRs (average age 50.6 years) were studied. In 2014/2016 86 HD patients (average age 66.2 years), 861 RTRs (average age 52 years) were studied. The antihypertensive treatment analysis was based on medical records and mean pressure was calculated from 3 consecutive visits in RTRs and 6 consecutive dialysis in HD patients. HT, cardiovascular diseases and diabetes were diagnosed in 94.9, 71.4, 39.3% in 2006 and 98.8, 65.9, 34.1% in 2016 - HD patients and in 95, .21, 23% in 2014 and 95.8, 17.7, 16.5% in 2016 - RTRs. Results The target of blood pressure control according to recommendations was achieved in 64.3% (2006) and 49,4% (2016) in HD patients and in 61.4% (2006) and 49.4% (2014) in RTRs. 3 drugs (28.6 and 33.5% -2006), (30,6 and 29.1% -2016/2014) or 2 drugs antihypertensive therapy (19.6 and 26.9% 2006), (22. 4 and 27.1% - 2016/2014) was used in HD patients and RTRs, respectively. Conclusion 1. The target blood pressure control was achieved in both groups in a low percentage of patients. 2. RTRs more often required multi-drug antihypertensive therapy to control blood pressure than HD patients. 3. There is necessary to improve the control of hypertension, because it is associated with better kidney graft survival.